Express Scripts (NASDAQ: ESRX ) investors need to consider some of the risks in buying shares of the company. In this video, Fool Jim Mueller outlines three risks to the company's future health. Acquisitions, for example, may be more difficult to come by as Express Scripts could be viewed as having a monopoly on the pharmacy management business. Will the economy discourage new customers? Will synergies be achieved with its acquisitions? Investors need to think about these matters before jumping in.
RSS Headlines
Fool UK
Comments from our Foolish Readers
Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the
Report this Comment icon found on every comment.
Report this Comment On March 22, 2013, at 11:12 PM, bestwaytoriches wrote:
Once you free up some cash for the next Investment consider Rad $ 1.90 Most professional money managers predict RAD will triple in 2013 with a price target Dec $ 3.20 and Dec 2014 $ 7.40 and Dec. 2015$ 11. all these figure can be confirmed by the point and figure charts. Rad has turned the confirmed from losing money to now profitable and raising guidance and receiving upgrades. RAD is currently 1/10 the price of it's peers. As Rad continue to confirm results institutions will add to there position and RAD will excellorate north.
Add your comment.